If you need more lookups,
subscriptions start at $34 USD/month.
B. Silber Location
San Francisco, CA, US
B. Silber Work
2024 -now Chairman, CEO and President @ AuriculoCranialTherapy, Inc.
2023 -now Scientific Advisor @
2019 -now Key and Lead Independent Expert - Pharma and Biotech - Corporate - Patent - Litigation - Trade Secrets @ Dr. B. Michael Silber
now Reiley Pharmaceuticals, Inc. @
2013 -now Scientific Advisor @
2024 -now Chairman, CEO and President @ AuriculoCranialTherapy, Inc.
2014 -now President and Chief Executive Officer @
2007 -now Professor, Department of Bioengineering and Therapeutic Sciences @
2022 -now Scientific Advisory Board Member @ Nucleusrx
2015 -2022 President and Chief Executive Officer @ Macregen
2014 -now President and Chief Executive Officer @ Reiley Pharmaceuticals
2012 -2014 President and Chief Executive Officer @ Elmedtech
2013 -now Senior Advisor @
2007 -2012 Chief, Drug Discovery R and D, Professor of Neurology, and Bioengineering and Therapeutic Sciences @
2010 -now Senior Advisor @ Vivonyx
2005 -2007 Senior Vice Research and Development @
2006 -now Senior Advisor @ Novakos
2002 -2005 Vice Research and Development @
2004 -now Senior Advisor @ Neurokos
1990 -2002 Director and Head, Genomic and Proteomic Sciences, DMPK @
1988 -1990 Senior Research and Development @
1983 -1988 Director, Drug Metabolism, Pharmacokinetics, Research and Development @
1981 -1983 Assistant Professor, Department of Pharmaceutics and Medicinal Chemistry @
B. Silber Education
University Of California - San Francisco
Doctor Of Philosophy (Chemistry, Pharmacology)
1978-1981
B. Silber Skills
IND
Translational Medicine
Biotechnology
Clinical Pharmacology
Neuroscience
Medical Devices
Validation
Protein Chemistry
Cell Culture
Clinical Trials
Proteomics
Pharmaceuticals
Infectious Diseases
GMP
Drug Delivery
Bioinformatics
Medical Education
Cell Biology
Oncology
Teaching
Clinical Research
Marketing
Drug Discovery
Technology Transfer
Healthcare IT
Biomarkers
Genomics
Pharmaceutical Industry
R&d
Clinical
Medicinal Chemistry
Public Speaking
Pharmacology
Genetics
Immunology
Life Sciences
Clinical Development
Pharmacokinetics
Healthcare
Cell Based Assays
Strategic Planning
Neurology
Biochemistry
FDA
In Vitro
Customer Service
SAN
Molecular Biology
Diagnostics
Toxicology
Neuropharmacology
Sales
Project Management
Research
GLP
Neurodegenerative Diseases
B. Silber Summary
B. Silber, based in San Francisco, CA, US, is currently a Chairman, CEO and President at AuriculoCranialTherapy, Inc.. B. Silber brings experience from previous roles at Osanni Bio, Dr. B. Michael Silber, Reiley Pharmaceuticals, Inc. and Clinakos. B. Silber holds a 1978 - 1981 Doctor Of Philosophy in Chemistry, Pharmacology @ University Of California - San Francisco. With a robust skill set that includes IND, Translational Medicine, Biotechnology, Clinical Pharmacology, Neuroscience and more. B. Silber has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different B. Silber?
Find contact details for 700 million professionals.